DG
33
-9
CAT
40
-2
APH
48
2
L
55
10
ECL
47
-7
CF
35
3
LH
46
8
MA
57
2
EMR
54
3
ABT
60
-5
COP
47
17
NTAP
37
2
ISRG
56
2
PRU
54
3
RL
59
4
HSIC
53
-6
TSN
50
-2
FIS
62
4
HP
32
2
SPG
43
3
DG
33
-9
CAT
40
-2
APH
48
2
L
55
10
ECL
47
-7
CF
35
3
LH
46
8
MA
57
2
EMR
54
3
ABT
60
-5
COP
47
17
NTAP
37
2
ISRG
56
2
PRU
54
3
RL
59
4
HSIC
53
-6
TSN
50
-2
FIS
62
4
HP
32
2
SPG
43
3
Financhill
Back

T-Mobile US Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
66

TMUS
T-Mobile US

Last Price:
$261.97
Seasonality Move:
6.54%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$97.77
Seasonality Move:
6.73%
Buy
66
T-Mobile US (TMUS) is a Buy

Is T-Mobile US a Buy, Sell or Hold?

  • The current T-Mobile US [TMUS] share price is $255.61. The Score for TMUS is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • TMUS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TMUS Stock Price Chart

What is T-Mobile US's stock price today?

  • The T-Mobile US share price today is $255.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMUS is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

TMUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.11 Buy
Relative Strength Index (14 RSI): 48.52 Sell
Chaikin Money Flow: 2746919 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (251.57 - 269.45) Sell
Bollinger Bands (100): (218.74 - 253) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

TMUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 263.8 Sell
20-day SMA: 264.19 Sell
50-day SMA: 240.46 Buy
200-day SMA: 212.44 Buy
8-day EMA: 261.56 Sell
20-day EMA: 259.44 Sell
50-day EMA: 247.77 Buy
200-day EMA: 216.84 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

T-Mobile US Earnings Growth & TMUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.93 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and an increase next year of $2.20 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

T-Mobile US Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):